CAR-T therapy tested as First-Line treatment for myeloma
NCT ID NCT06045806
Summary
This study is testing whether adding a personalized immune cell therapy (called ide-cel) to standard maintenance medication (lenalidomide) works better than the standard medication alone for adults with newly diagnosed multiple myeloma. It focuses on patients who had a stem cell transplant but whose cancer did not respond as well as hoped. The main goal is to see if the combination keeps the cancer from getting worse for a longer time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando
Orlando, Florida, 32804, United States
-
Asan Medical Center
Seoul, Seoul-teukbyeolsi, 05505, South Korea
-
Ascension Providence Hospital
Southfield, Michigan, 48075, United States
-
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
Nantes, Pays de la Loire Region, 44000, France
-
Chiba University Hospital
Chiba, 260-8677, Japan
-
Chonnam National University Hwasun Hospital
Hwasun, Jeonranamdo, 58128, South Korea
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Henri Mondor Hospital
Créteil, Val-de-Marne, 94010, France
-
Hokkaido University Hospital
Sapporo, Hokkaido, 060-8648, Japan
-
Hopital Claude Huriez - CHU de Lille
Lille, Nord, 59000, France
-
Hospital Clínic de Barcelona
Barcelona, Catalunya [Cataluña], 08036, Spain
-
Hospital Universitari i Politecnic La Fe
Valencia, 46026, Spain
-
Hyogo Medical University Hospital
Nishinomiya, Hyōgo, 663-8501, Japan
-
Institut Paoli-Calmettes
Marseille, Bouches-du-Rhône, 13273, France
-
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE
Toulouse, 31100, France
-
Japanese Red Cross Medical Center
Shibuya-ku, Tokyo, 150-8935, Japan
-
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, 920-8641, Japan
-
Kyushu University Hospital
Fukuoka, 812-8582, Japan
-
Local Institution - 0001
Hamilton, Ontario, L8V5C2, Canada
-
Local Institution - 0004
Melbourne, Victoria, 3000, Australia
-
Local Institution - 0005
Brisbane, Queensland, 4029, Australia
-
Local Institution - 0006
Melbourne, Victoria, 3004, Australia
-
Local Institution - 0007
Camperdown, New South Wales, 2050, Australia
-
Local Institution - 0008
Melbourne, Victoria, 3065, Australia
-
Local Institution - 0011
Murdoch, Western Australia, 6150, Australia
-
Local Institution - 0012
Pamplona, Navarre, 31008, Spain
-
Local Institution - 0013
Salamanca, 37007, Spain
-
Local Institution - 0017
L'Hospitalet Del Llobregat, Barcelona [Barcelona], 08908, Spain
-
Local Institution - 0020
Badalona, Barcelona [Barcelona], 08916, Spain
-
Local Institution - 0021
Madrid, 28041, Spain
-
Local Institution - 0022
Gliwice, Silesian Voivodeship, 44-101, Poland
-
Local Institution - 0023
Warsaw, Masovian Voivodeship, 02-776, Poland
-
Local Institution - 0024
Poznan, 60-569, Poland
-
Local Institution - 0026
Gdansk, 80-952, Poland
-
Local Institution - 0027
Lublin, Lublin Voivodeship, 20-090, Poland
-
Local Institution - 0028
Villejuif, Val-de-Marne, 94805, France
-
Local Institution - 0029
Poitiers, Vienne, 86021, France
-
Local Institution - 0031
Paris, Île-de-France Region, 75571, France
-
Local Institution - 0038
Seoul, Seoul Teugbyeolsi, 06351, South Korea
-
Local Institution - 0043
Seoul, Seoul Teugbyeolsi, 06591, South Korea
-
Local Institution - 0046
Pierre-Bénite, Rhône, 69310, France
-
Local Institution - 0047
Pessac, Aquitaine, 33600, France
-
Local Institution - 0055
Beersheba, Southern District, 8410101, Israel
-
Local Institution - 0056
Haifa, 31096, Israel
-
Local Institution - 0057
Ramat Gan, Central District, 5262100, Israel
-
Local Institution - 0058
Petah Tikva, Central District, 4910021, Israel
-
Local Institution - 0059
Jerusalem, 9112001, Israel
-
Local Institution - 0060
Thessaloniki, Thessaloníki, 570 10, Greece
-
Local Institution - 0061
Athens, Attikí, 106 76, Greece
-
Local Institution - 0062
Chaïdári, Attikí, 12462, Greece
-
Local Institution - 0063
Pátrai, Achaḯa, 26504, Greece
-
Local Institution - 0064
Rozzano, Milano, 20089, Italy
-
Local Institution - 0065
Bologna, 40138, Italy
-
Local Institution - 0066
Roma, 00161, Italy
-
Local Institution - 0069
Oslo, 0372, Norway
-
Local Institution - 0070
Odense, Region Syddanmark, 5000, Denmark
-
Local Institution - 0071
Shimotsuke, 329-0498, Japan
-
Local Institution - 0072
Heidelberg, Baden-Wurttemberg, 69120, Germany
-
Local Institution - 0073
Cologne, North Rhine-Westphalia, 50937, Germany
-
Local Institution - 0074
Würzburg, 97080, Germany
-
Local Institution - 0076
Hamburg, 20246, Germany
-
Local Institution - 0077
Nuremberg, Bavaria, 90419, Germany
-
Local Institution - 0078
Ulm, Baden-Wurttemberg, 89081, Germany
-
Local Institution - 0079
Dresden, 01307, Germany
-
Local Institution - 0080
London, London, City of, SE5 9RS, United Kingdom
-
Local Institution - 0082
Paris, 75010, France
-
Local Institution - 0083
Anderlecht, Bruxelles-Capitale, Région de, 1070, Belgium
-
Local Institution - 0084
Brussels, Bruxelles-Capitale, Région de, 1090, Belgium
-
Local Institution - 0085
Isehara, Kanagawa, 259-1193, Japan
-
Local Institution - 0087
Leipzig, Saxony, 04103, Germany
-
Local Institution - 0088
Tel Aviv, Tell Abīb, 6423906, Israel
-
Local Institution - 0089
Salzburg, 5020, Austria
-
Local Institution - 0090
Vienna, 1090, Austria
-
Local Institution - 0091
Bucharest, 022328, Romania
-
Local Institution - 0093
Birmingham, England, B15 2TH, United Kingdom
-
Local Institution - 0094
London, London, City of, W12 0HS, United Kingdom
-
Local Institution - 0095
Warsaw, Masovian Voivodeship, 02-097, Poland
-
Local Institution - 0104
Atlanta, Georgia, 30342, United States
-
Local Institution - 0109
Houston, Texas, 77030, United States
-
Local Institution - 0113
Sacramento, California, 95817, United States
-
Local Institution - 0115
Essen, 45122, Germany
-
Local Institution - 0121
Atlanta, Georgia, 30322, United States
-
Local Institution - 0124
Austin, Texas, 78704, United States
-
Local Institution - 0126
Orange, California, 92868, United States
-
Local Institution - 0131
Los Angeles, California, 90095, United States
-
Local Institution - 0132
Philadelphia, Pennsylvania, 19104, United States
-
Local Institution - 0133
Edmonton, Alberta, T6G 1Z2, Canada
-
Local Institution - 0134
Montreal, Quebec, H1T 2M4, Canada
-
Local Institution - 0144
Brussels, Bruxelles-Capitale, Région de, 1200, Belgium
-
Local Institution - 0151
Boston, Massachusetts, 02215, United States
-
M Health Fairview Clinics and Surgery Center
Minneapolis, Minnesota, 55455, United States
-
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
-
Novant Health Cancer Institute - Elizabeth
Charlotte, North Carolina, 28204, United States
-
Okayama University Hospital
Okayama, 700-8558, Japan
-
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi, 03080, South Korea
-
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Washington University School of Medicine
St Louis, Missouri, 63108, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.